ArticleJournal of clinical laboratory analysis2022

MicroRNA-338-3p as a therapeutic target in cardiac fibrosis through FGFR2 suppression.

Cheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.